Abstract Background Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used therapies for cardiovascular risk reduction in type 2 diabetes (T2D)
Epidemiologic reviews have displayed a bidirectional relationship between diabetes and depression, suggesting that patients with depression potentially have a 41% increased risk of developing diabetes, while patients with type 2 diabetes would have a twofold risk of depression as controls (33)
Practice guideline: treatment for insomnia and disrupted sleep behavior in children and adolescents with autism spectrum disorder: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology
Hypertension 79, e21e41.CrossRefGoogle ScholarPubMed et al
Contact your doctor immediately if you experience: Severe or persistent headaches Blurred vision or confusion Dizziness or fainting Nausea and vomiting that prevent hydration Signs of an allergic reaction (rash, swelling, or difficulty breathing) These could indicate more serious side effects of semaglutide or other potential complications requiring professional medical advice
